Ambit files for IPO

Ambit Biosciences Corp. (San Diego, Calif.) proposed to raise up to $57.5 million in an IPO underwritten by Citigroup; Leerink; BMO Capital Markets; and Baird. Ambit's lead compound is quizartinib, wh...